What is Evvy?
Evvy operates as a provider of at-home testing solutions and a wellness company specifically tailored for women. Founded in 2021 and based in New York, NY, Evvy aims to empower women with accessible and comprehensive health insights through its innovative testing services. The company's approach integrates diagnostic capabilities with a wellness-focused strategy, addressing a critical need in the healthcare market for personalized and convenient health management tools.
How much funding has Evvy raised?
Evvy has raised a total of $19M across 2 funding rounds:
Angel/Seed
$5M
Series A
$14M
Angel/Seed (2021): $5M with participation from Box Group, Virtue, Human Ventures, BBG Ventures, G9 Ventures, and General Catalyst
Series A (2023): $14M led by Labcorp, General Catalyst, RH Capital, Virt Investments, and Left Lane Capital
Key Investors in Evvy
Labcorp
Labcorp is a global leader in diagnostic services and drug development, providing vital information to help doctors, hospitals, and researchers make critical decisions. Their involvement suggests a strategic alignment with Evvy's testing and data capabilities.
General Catalyst
General Catalyst is a prominent venture capital firm that invests in transformational companies across various sectors, including healthcare. Their continued support for Evvy highlights a belief in the company's disruptive potential and scalable business model.
Left Lane Capital
Left Lane Capital is a venture capital and growth equity firm focused on high-growth consumer internet and technology companies. Their investment in Evvy indicates a strategic interest in innovative consumer health-tech solutions.
What's next for Evvy?
With its recent major strategic investment and a substantial overall funding base of $19M, Evvy is poised to accelerate its product development and market penetration. The company's Series A financing, in particular, signals a transition towards scaling operations and expanding its service offerings. Future growth will likely involve enhancing its testing technology, broadening its customer reach, and potentially forging new strategic partnerships within the healthcare and wellness sectors. The sustained investor confidence, evidenced by repeat backing from firms like General Catalyst, suggests a strong belief in Evvy's long-term vision and its potential to disrupt the women's health market.
See full Evvy company page
